跳至主要内容
临床试验/IRCT201211239014N13
IRCT201211239014N13已完成2 期

Effect of selenium therapy on primary autoimmune hypothyroidism: a randomized clinical trial

Vice chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 75 years(—)
性别
All

入选标准

  • (a) age of 18 to 75 years; (b) having primary autoimmune hypothyroidisms; (c) having anti-TPO >200 U/ml
  • Exclusion criteria: (a) history of Thyroid surgery; (b) history of thyroid cancer; (c) hypothyroidism resulted from hyperthyroidism; (d) history of auto-immune disease and known rheumatologic diseases; (e) pregnancy; (f) renal failure; (g) subclinical hypothyroidism; (h) history of using radioactive iodine, anti thyroid medication, cytotoxic; immunosuppressive, glucocorticoid, amiodaron, lithium, interferon, and chemotherapy

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验